NOTICE OF EXTRAORDINARY GENERAL MEETING

The board of directors of DiaGenic ASA (the “Company”) hereby convenes an extraordinary general meeting. Time: 18 December 2009 at 10:00 hours (CET) Place: Grenseveien 92, Oslo, Norway Agenda: 1. Opening of the meeting by chairman of the board Håkon Sæterøy, including the taking of attendance of shareholders present 2. Election of chairman of the meeting and a person to co-sign the minutes 3. Approval of notice and agenda 4. Share capital increase by issue of new shares 5. Issue of warrants 6. Amendment of the articles of association concerning notice period for general meetings 7. Amendment of the articles of association concerning distribution of annual report and other documents for the general meeting 8. Amendment of subscription price for previously issued warrants Please find Notice to Extraordinary General Meeting attached, Selected information regarding subscription rights for repair issue (Item 4): On 25 November 2009 the Company carried out a private placement. With consideration to the principle of equal treatment of the Company’s shareholders, the board of directors proposes that shareholders as of 25 November 2009 that did not participate in the private placement, will be allotted one pre-emptive right for each 11.72 shares. The number of subscription rights to be issued to each shareholder will be rounded down to the nearest whole subscription right. Each subscription right will entitle the holder thereof to subscribe for one new share on equal terms as in the private placement and issued subscription rights shall be applied for listing on Oslo Børs. All shareholders are entitled to participate at the general meeting. Shareholders who cannot participate at the general meeting in person may authorize the chairman of the board or another person to vote for their shares by using the proxy form attached as annex 1. The proxy form may be sent to the Company per e-mail to ruben.ekbraten@diagenic.com, per fax +47 23 24 89 59 or be delivered to the proxy holder and brought to the general meeting. Pursuant to the Company’s article of association section 10, it is decided that shareholders and proxy holders who wish to participate at the general meeting, must notify the Company of his/her presence by use of the attendance form attached hereto annex 2. Completed attendance form must be received by the Company within 17 December 2009. Information regarding the extraordinary general meeting, including this notice with attachments and the Company’s articles of association, is available at the Company’s website www.diagenic.com. Please contact Håkon Sæterøy, Chairman of the board, for more information regarding the Extraordinary General Meeting, telephone +47 92 69 51 75